Calcium Channel Blockers in Non-responders to Vasoreactivity Testing in Pulmonary Arterial Hypertension: A Literature Review
M. Malki, N. Loudiyi, Z. Lakhal & A. BENYASS · Asian Journal of Cardiology Research · 2026
Background: In pulmonary arterial hypertension (PAH), high-dose calcium channel blockers (CCBs) are appropriate for selected patients who demonstrate acute vasoreactivity and maintain a favourable response. Their inappropriate use in non-responders may cause haemodynamic deterior...
Open access
Research Article
10.9734/ajcr/2026/v9i1411